Benefit-risk balance of fibrinolytic therapy in ST-elevation myocardial infarction as evaluated by physicians

Eur J Emerg Med. 2023 Jun 1;30(3):216-218. doi: 10.1097/MEJ.0000000000001020. Epub 2023 Apr 24.

Authors

Alexandre Pineda¹, Dominique Savary², Amélie Vromant³, Frédéric Lapostolle¹

Affiliations

¹ SAMU 93 - UF Recherche-Enseignement-Qualité, Université Paris 13, Sorbonne Paris Cité, Inserm U942, Hôpital Avicenne, Bobigny.
² SAMU 49 - Urgences adultes, Centre Hospitalier Universitaire, Angers.
³ SAMU 59, CHRU de Lille, Lille, France.

PMID: 37103903
DOI: 10.1097/MEJ.0000000000001020

No abstract available

Publication types

Letter

MeSH terms

Electrocardiography
Humans
Myocardial Infarction* / drug therapy
Physicians*
Risk Assessment
ST Elevation Myocardial Infarction* / drug therapy
Thrombolytic Therapy